title: Regulation of scleral cell contraction by transforming growth factor-beta and stress: competing roles in myopic eye growth.
abstract: Reduced extracellular matrix accumulation in the sclera of myopic eyes leads to increased ocular extensibility and is related to reduced levels of scleral transforming growth factor-beta (TGF-beta). The current study investigated the impact of this extracellular environment on scleral cell phenotype and cellular biomechanical characteristics. Scleral cell phenotype was investigated in vivo in a mammalian model of myopia using the myofibroblast marker, alpha-smooth muscle actin (alpha-SMA). In eyes developing myopia alpha-SMA levels were increased, suggesting increased numbers of contractile myofibroblasts, and decreased in eyes recovering from myopia. To understand the factors regulating this change in scleral phenotype, the competing roles of TGF-beta and mechanical stress were investigated in scleral cells cultured in three-dimensional collagen gels. All three mammalian isoforms of TGF-beta altered scleral cell phenotype to produce highly contractile, alpha-SMA-expressing myofibroblasts (TGF-beta3>TGF-beta2>TGF-beta1). Exposure of cells to the reduced levels of TGF-beta found in the sclera in myopia produced decreased cell-mediated contraction and reduced alpha-SMA expression. These findings are contrary to the in vivo gene expression data. However, when cells were exposed to both the increased stress and the reduced levels of TGF-beta found in myopia, increased alpha-SMA expression was observed, replicating in vivo findings. These results show that although reduced scleral TGF-beta is a major contributor to the extracellular matrix remodeling in the myopic eye, it is the resulting increase in scleral stress that dominates the competing TGF-beta effect, inducing increased alpha-SMA expression and, hence, producing a larger population of contractile cells in the myopic eye.
authors.affiliation: Department of Optometry and Vision Sciences, The University of Melbourne, Victoria 3010, Australia.
authors.forename: Andrew I
authors.initials: AI
authors.lastname: Jobling
authors.forename: Alex
authors.initials: A
authors.lastname: Gentle
authors.forename: Ravikanth
authors.initials: R
authors.lastname: Metlapally
authors.forename: Bryan J
authors.initials: BJ
authors.lastname: McGowan
authors.forename: Neville A
authors.initials: NA
authors.lastname: McBrien
mesh_terms: D000199:Actins / Q000378:metabolism; D000818:Animals; D048430:Cell Shape / Q000187:drug effects*; D002478:Cells, Cultured; D009216:Myopia / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D020033:Protein Isoforms / Q000378:metabolism; D012590:Sclera / Q000187:drug effects* / Q000378:metabolism* / Q000473:pathology; D013312:Stress, Physiological; D016212:Transforming Growth Factor beta / Q000378:metabolism / Q000494:pharmacology*; D014417:Tupaia / Q000235:genetics / Q000378:metabolism
chemical_list: D000199:Actins; D020033:Protein Isoforms; D016212:Transforming Growth Factor beta